Compare $NVCT vs $OLMA | Chartloom

Compare

$NVCT vs $OLMA

Nuvectis Pharma Inc · Olema Pharmaceuticals Inc

NVCT

Nuvectis Pharma Inc

OLMA

Olema Pharmaceuticals Inc

Compare $NVCT vs $OLMA

Comparing Nuvectis Pharma Inc and Olema Pharmaceuticals Inc

NVCTNuvectis Pharma Inc

OLMAOlema Pharmaceuticals Inc

NVCTNuvectis Pharma Inc

Market cap

$666M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

148.2%

52W performance

239.0%

FCF yield

-2.9%

OLMAOlema Pharmaceuticals Inc

Market cap

$683M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.1%

52W performance

-27.1%

FCF yield

-24.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NVCT

OLMA

Detailed metrics comparison

NVCT

Nuvectis Pharma Inc

OLMA

Olema Pharmaceuticals Inc

Market Cap

NVCT$666M

OLMA$683M

Enterprise Value

NVCT$644M

OLMA$637M

Price

NVCT$21.12

OLMA$7.82

P/E Ratio

NVCTN/A

OLMAN/A

P/S Ratio

NVCT0.00x

OLMA0.00x

EV/Sales

NVCT0.00x

OLMA0.00x

EV/EBITDA

NVCT0.00x

OLMA0.00x

P/B Ratio

NVCT78.79x

OLMA1.67x

P/FCF Ratio

NVCTN/A

OLMAN/A

EV/FCF

NVCT-33.00x

OLMA-3.86x

PEG Ratio

NVCTN/A

OLMAN/A

Forward P/E (NTM)

NVCTN/A

OLMAN/A

Forward P/S (NTM)

NVCTN/A

OLMAN/A

Revenue (TTM)

NVCT$0

OLMA$0

Revenue Growth (YoY)

NVCTN/A

OLMAN/A

Forward Rev Growth

NVCT0.0%

OLMA820.6%

Gross Margin (TTM)

NVCT0.0%

OLMA0.0%

Operating Margin (TTM)

NVCT0.0%

OLMA0.0%

EBITDA Margin (TTM)

NVCT0.0%

OLMA0.0%

Net Margin (TTM)

NVCT0.0%

OLMA0.0%

FCF Margin (TTM)

NVCTN/A

OLMAN/A

Net Income (TTM)

NVCT$-30M

OLMA$-205M

FCF (TTM)

NVCT$-20M

OLMA$-165M

EPS (TTM)

NVCT-$1.29

OLMA-$1.96

ROE (TTM)

NVCT-16947.0%

OLMA-4822.0%

ROA (TTM)

NVCT-9680.0%

OLMA-4300.0%

ROIC (TTM)

NVCT-16947.0%

OLMA-4788.0%

Cash

NVCT$22M

OLMA$49M

Debt

NVCT$0

OLMA$3M

Net Cash/Debt

NVCT$22M

OLMA$46M

Current Ratio (TTM)

NVCT1.68x

OLMA8.86x

Quick Ratio (TTM)

NVCT1.68x

OLMA8.75x

Debt/Equity (TTM)

NVCT0.00x

OLMA0.01x

Debt/Assets (TTM)

NVCT0.0%

OLMA0.0%

Interest Coverage (TTM)

NVCTN/A

OLMAN/A

Net Debt/EBITDA (TTM)

NVCT0.00x

OLMA0.00x

Beta

NVCT-0.23

OLMA1.98

52W Performance

NVCT239.0%

OLMA-27.1%

YTD Performance

NVCT148.2%

OLMA-69.1%

% from 52W High

NVCT-27.9%

OLMA-78.4%

% from 52W Low

NVCT280.5%

OLMA17.6%

Asset Turnover (TTM)

NVCT0.00x

OLMA0.00x

FCF Yield (TTM)

NVCT-2.9%

OLMA-24.1%

Earnings Yield (TTM)

NVCT-4.5%

OLMA-29.9%

Dividend Yield (TTM)

NVCTN/A

OLMAN/A

Rule of 40

NVCT0.0

OLMA0.0

EV/GP/RG

NVCTN/A

OLMAN/A

Ticker research

View NVCT research View OLMA research

Metric	NVCT Nuvectis Pharma Inc	OLMA Olema Pharmaceuticals Inc
Market & Valuation
Market Cap	$666M	$683M
Enterprise Value	$644M	$637M
Price	$21.12	$7.82
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	78.79x	1.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-33.00x	-3.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	820.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-30M	$-205M
FCF (TTM)	$-20M	$-165M
EPS (TTM)	-$1.29	-$1.96
ROE (TTM)	-16947.0%	-4822.0%
ROA (TTM)	-9680.0%	-4300.0%
ROIC (TTM)	-16947.0%	-4788.0%
Financial Health
Cash	$22M	$49M
Debt	$0	$3M
Net Cash/Debt	$22M	$46M
Current Ratio (TTM)	1.68x	8.86x
Quick Ratio (TTM)	1.68x	8.75x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.23	1.98
52W Performance	239.0%	-27.1%
YTD Performance	148.2%	-69.1%
% from 52W High	-27.9%	-78.4%
% from 52W Low	280.5%	17.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-2.9%	-24.1%
Earnings Yield (TTM)	-4.5%	-29.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NVCT research	View OLMA research

Valuation

P/S Ratio

NVCT

0.00x

OLMA

0.00x

EV/FCF

NVCT

-33.00x

OLMA

-3.86x

Growth & revenue

Forward Revenue Growth

OLMA

820.6%

NVCT

0.0%

Profitability & performance

Gross Margin

NVCT

0.0%

OLMA

0.0%

ROE

OLMA

-4822.0%

NVCT

-16947.0%

FCF Yield %

NVCT

-2.9%

OLMA

-24.1%

52-Week Performance

NVCT

239.0%

OLMA

-27.1%

Detailed metrics comparison

NVCT

Nuvectis Pharma Inc

OLMA

Olema Pharmaceuticals Inc

Market Cap

NVCT$666M

OLMA$683M

Enterprise Value

NVCT$644M

OLMA$637M

Price

NVCT$21.12

OLMA$7.82

P/E Ratio

NVCTN/A

OLMAN/A

P/S Ratio

NVCT0.00x

OLMA0.00x

EV/Sales

NVCT0.00x

OLMA0.00x

EV/EBITDA

NVCT0.00x

OLMA0.00x

P/B Ratio

NVCT78.79x

OLMA1.67x

P/FCF Ratio

NVCTN/A

OLMAN/A

EV/FCF

NVCT-33.00x

OLMA-3.86x

PEG Ratio

NVCTN/A

OLMAN/A

Forward P/E (NTM)

NVCTN/A

OLMAN/A

Forward P/S (NTM)

NVCTN/A

OLMAN/A

Revenue (TTM)

NVCT$0

OLMA$0

Revenue Growth (YoY)

NVCTN/A

OLMAN/A

Forward Rev Growth

NVCT0.0%

OLMA820.6%

Gross Margin (TTM)

NVCT0.0%

OLMA0.0%

Operating Margin (TTM)

NVCT0.0%

OLMA0.0%

EBITDA Margin (TTM)

NVCT0.0%

OLMA0.0%

Net Margin (TTM)

NVCT0.0%

OLMA0.0%

FCF Margin (TTM)

NVCTN/A

OLMAN/A

Net Income (TTM)

NVCT$-30M

OLMA$-205M

FCF (TTM)

NVCT$-20M

OLMA$-165M

EPS (TTM)

NVCT-$1.29

OLMA-$1.96

ROE (TTM)

NVCT-16947.0%

OLMA-4822.0%

ROA (TTM)

NVCT-9680.0%

OLMA-4300.0%

ROIC (TTM)

NVCT-16947.0%

OLMA-4788.0%

Cash

NVCT$22M

OLMA$49M

Debt

NVCT$0

OLMA$3M

Net Cash/Debt

NVCT$22M

OLMA$46M

Current Ratio (TTM)

NVCT1.68x

OLMA8.86x

Quick Ratio (TTM)

NVCT1.68x

OLMA8.75x

Debt/Equity (TTM)

NVCT0.00x

OLMA0.01x

Debt/Assets (TTM)

NVCT0.0%

OLMA0.0%

Interest Coverage (TTM)

NVCTN/A

OLMAN/A

Net Debt/EBITDA (TTM)

NVCT0.00x

OLMA0.00x

Beta

NVCT-0.23

OLMA1.98

52W Performance

NVCT239.0%

OLMA-27.1%

YTD Performance

NVCT148.2%

OLMA-69.1%

% from 52W High

NVCT-27.9%

OLMA-78.4%

% from 52W Low

NVCT280.5%

OLMA17.6%

Asset Turnover (TTM)

NVCT0.00x

OLMA0.00x

FCF Yield (TTM)

NVCT-2.9%

OLMA-24.1%

Earnings Yield (TTM)

NVCT-4.5%

OLMA-29.9%

Dividend Yield (TTM)

NVCTN/A

OLMAN/A

Rule of 40

NVCT0.0

OLMA0.0

EV/GP/RG

NVCTN/A

OLMAN/A

Ticker research

View NVCT research View OLMA research

Metric	NVCT Nuvectis Pharma Inc	OLMA Olema Pharmaceuticals Inc
Market & Valuation
Market Cap	$666M	$683M
Enterprise Value	$644M	$637M
Price	$21.12	$7.82
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	78.79x	1.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-33.00x	-3.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	820.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-30M	$-205M
FCF (TTM)	$-20M	$-165M
EPS (TTM)	-$1.29	-$1.96
ROE (TTM)	-16947.0%	-4822.0%
ROA (TTM)	-9680.0%	-4300.0%
ROIC (TTM)	-16947.0%	-4788.0%
Financial Health
Cash	$22M	$49M
Debt	$0	$3M
Net Cash/Debt	$22M	$46M
Current Ratio (TTM)	1.68x	8.86x
Quick Ratio (TTM)	1.68x	8.75x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.23	1.98
52W Performance	239.0%	-27.1%
YTD Performance	148.2%	-69.1%
% from 52W High	-27.9%	-78.4%
% from 52W Low	280.5%	17.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-2.9%	-24.1%
Earnings Yield (TTM)	-4.5%	-29.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NVCT research	View OLMA research